February 2021, Qompium, Belgium

/in /by

February 2021, Qompium, Belgium, a pioneering digital health company with business units Fibricheck (https://www.fibricheck.com)  and Extra Horizon (https://www.extrahorizon.com/en-us/home), raised an additional 9 million euro in venture funding. FibriCheck is a medical app that lets people monitor their heart rhythm and thereby detect hidden heart rhythm disorders such as atrial fibrillation (AF). It is the world’s first CE and FDA approved medical smartphone app for heart rhythm disorders using a camera signal. Extra Horizon is a platform that enables medical applications to go to market with far greater speed and scalability, by providing the entire backend or technical framework of such applications.